Daily Management Review

A UN Assessment Finds China Winning The Fight For Generative AI Patents


A UN Assessment Finds China Winning The Fight For Generative AI Patents
According to U.N. data released on Wednesday, China is well ahead of other nations in developing generative AI products like chatbots, submitting six times as many patents as its nearest competitor, the United States.
The World Intellectual Property Organisation (WIPO), which is in charge of overseeing a system for countries to share recognition of patents, reports that over 50,000 patent applications have been filed in the past ten years in the field of generative artificial intelligence (AI), which creates text, images, computer code, and even music from pre-existing information.
It stated that just 25% of them were submitted in 2023.
"This region is growing." This is a region that is expanding more quickly. Additionally, we anticipate further growth there," WIPO Patent Analytics Manager Christopher Harrison told reporters.
According to WIPO, China registered more than 38,000 GenAI innovations between 2014 and 2023, whereas the US filed 6,276 throughout the same time period.
Harrison stated that a wide range of industries, including document management, publishing, and autonomous driving, were covered by the Chinese patent filings.
According to the statistics, India was increasing at the highest pace, followed by South Korea, Japan, and South Korea in the rankings of third, fourth, and fifth, respectively.
China's ByteDance, the parent company of the popular video app TikTok, Alibaba Group, a major player in Chinese e-commerce, and Microsoft, a supporter of the firm OpenAI that developed ChatGPT, were among the top candidates.
While shops and other businesses are currently using chatbots that can imitate human speech to enhance customer service, GenAI has the potential to completely change a wide range of other economic areas, including research, publishing, transportation, and security, according to WIPO's Harrison.
This is AI Weekly—from Nvidia setting yet another record to Apple encountering difficulties in Europe.
In the scientific domain, GenAI-generated compounds hold promise for accelerating medication research. "The patent data suggests this is an area that is going to have a profound impact across many different industrial sectors going forward," WIPO's Harrison stated.
WIPO stated that it anticipates more patent applications in the near future and intends to provide an update of the data in the future, maybe utilising GenAI to highlight the pattern.